Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Finasteride helps improve treatment for benign prostatic hyperplasia.

Finasteride improves prostate cancer detection in PSA test.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Finasteride reduces prostate size and PSA levels in young patients.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Ganoderma lucidum may help treat enlarged prostate in rats.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Finasteride treats hair loss but may affect prostate cancer detection.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.